Glanbia plc (LON: GLB)
Market Cap | 2.85B |
Revenue (ttm) | 3.54B |
Net Income (ttm) | 232.71M |
Shares Out | n/a |
EPS (ttm) | 0.87 |
PE Ratio | 12.25 |
Forward PE | n/a |
Dividend | 0.31 (2.21%) |
Ex-Dividend Date | Aug 22, 2024 |
Volume | 3,893 |
Open | 15.10 |
Previous Close | 14.05 |
Day's Range | 13.43 - 15.10 |
52-Week Range | 13.00 - 19.62 |
Beta | n/a |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Nov 28, 2024 |
About Glanbia
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, ready-to-eat bars and snacking food, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing; research and development; property and land dealing; holding and management of receivables; prop... [Read more]
Financial Performance
In 2023, Glanbia's revenue was $5.43 billion, a decrease of -8.72% compared to the previous year's $5.94 billion. Earnings were $344.40 million, an increase of 26.90%.
Financial numbers in USD Financial StatementsNews
The Health Ingredients Market Surge: A $ 146.3 billion Industry Dominated by Kerry Group PLC (Ireland), DSM (Netherlands), and BASF SE (Germany)
Delray Beach, FL, Dec. 17, 2024 (GLOBE NEWSWIRE) -- The global health ingredients market is anticipated to grow at a compound annual growth rate (CAGR) of 7.8% from 2022 to 2027, expanding from $100.5...
Glanbia plc 2024 Q3 - Results - Earnings Call Presentation
The following slide deck was published by Glanbia plc in conjunction with their 2024 Q3 earnings call.
Dairy industry focused too much on the milk price former Glanbia boss Siobhn Talbot
The dairy industry sometimes focused too much on the short game of having a good milk price, former Group MD of Glanbia PLC, Siobhn Talbot, has said.
Glanbia plans to revamp operations for next phase of growth
Nutrition group Glanbia is embarking on an operational transformation that will see it separate its nutritionals business into two new segments.
Glanbia plc (GLAPF) Q2 2024 Earnings Call Transcript
Glanbia plc (OTCPK:GLAPF) Q2 2024 Earnings Conference Call August 14, 2024 3:30 AM ET Company Participants Liam Hennigan - Investor Relations Hugh McGuire - Chief Executive Officer Mark Garvey - Chief...
Glanbia plc (GLAPF) Q4 2023 Earnings Call Transcript
Glanbia plc (GLAPF) Q4 2023 Earnings Call Transcript
Glanbia: Fairly Valued For Current Performance
Glanbia has seen a 47% increase in value since August 2020, with its US nutrition business continuing to perform well. Profitability has been less impressive, with a net profit margin of 3.5% and post...
Glanbia plc (GLAPF) Q2 2023 Earnings Call Transcript
Glanbia plc (OTCPK:GLAPF) Q2 2023 Results Conference Call August 16, 2023 3:30 AM ET Company Participants Liam Hennigan - Group Secretary & Head-IR Siobhan Talbot - Group Managing Director Mark Garvey...
Glanbia plc (GLAPF) Q4 2022 Earnings Call Transcript
Glanbia plc (OTCPK:GLAPF) Q4 2022 Earnings Conference Call March 1, 2023 3:30 AM ET Company Participants Liam Hennigan - Secretary and Head of IR Siobhan Talbot - Group Managing Director Mark Garvey -...
Glanbia plc's (GLAPF) Q4 2021 Results - Earnings Call Transcript
Glanbia plc's (GLAPF) Q4 2021 Results - Earnings Call Transcript
Glanbia plc (GLAPF) Q2 2021 Results - Earnings Call Transcript
Glanbia plc (GLAPF) Q2 2021 Results - Earnings Call Transcript
Glanbia PLC (GLAPF) on Q4 2020 Results - Earnings Call Transcript
Glanbia PLC (GLAPF) on Q4 2020 Results - Earnings Call Transcript
Glanbia: A Name To Play The U.S. Nutrition Market
Glanbia is a London-listed Irish company but actually makes most of its money from U.S. nutrition businesses.